Daily as of 2 Nov 16:00 ET
- Price
- below both $29.73 vs 50 $32.29 / 200 $35.66
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 30 Sep 2026 · projected 26 bars out
COGT | Cogent BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$29.73
-$1.29 (-4.16%)
Cogent Biosciences (COGT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $31.02 vs 50 $35.90 / 200 $16.27
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 17 Nov 2025 · projected 18 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $31.01 vs 50 $30.65 / 200 $35.29
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 14 Sep 2026 · projected 24 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 30 Sep 2026 | 💀Death steep | daily | 26 bars out | Not tested |
| 14 Sep 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 10 Jul 2026 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 1 Apr 2026 | 💀Death | 4-hour | 30 bars out | 3 bar cross test |
| week of 17 Nov 2025 | 🟨Golden flat | weekly | 18 bars out | Not tested |
About COGT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$62M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid